An increasing trend of antipsychotic polypharmacy has been described in Western countries [ 4 ], and the prevalence rate is estimated to be between 27% and 60% [ 5 - 9 ].
← all excerpts
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis.
1
—
—